Nabazenil

Nabazenil
(IUPAC) ime
	(6,6,9-trimetil-3-(3-metiloktan-2-il)-7,8,9,10-tetrahidrobenzo[c]hromen-1-yl)-4-(azepan-1-il)butanoat
Klinički podaci
Identifikatori
CAS broj	58019-65-1
ATC kod	nije dodeljen
PubChem	163326
UNII	N1RX70K36C
Hemijski podaci
Formula	C35H55NO3
Mol. masa	537,814 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C35H55NO3/c1-7-8-11-15-26(3)27(4)28-23-31(38-33(37)16-14-21-36-19-12-9-10-13-20-36)34-29-22-25(2)17-18-30(29)35(5,6)39-32(34)24-28/h23-27H,7-22H2,1-6H3 ; Key: DRVZFWZGQKGHQO-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Nabazenil (SP-175) je sintetički agonist kanabinoidnog receptora, koji poseduje antikonvulsivna svojstva.^[3]^[4]

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Concise dictionary of pharmacological agents: properties and synonyms. p188. ISBN 0-7514-0499-3
↑ N. Aboul-Enein, M.; A. El-Azzouny, A.; A. Saleh, O.; A. Maklad, Y. (June 2012). „On Chemical Structures with Potent Antiepileptic/Anticonvulsant Profile”. Mini Reviews in Medicinal Chemistry (Bentham Science Publishers) 12 (7): 671-700.

	Portal Medicina
	Portal Hemija